November 07, 2025

NEC and the Cambodian Mine Action Center Successfully Predict Landmine-Contaminated Areas in Cambodia Using AI

NEC and the Cambodian Mine Action Center Successfully Predict Landmine-Contaminated Areas in Cambodia Using AI

– Achieving Over 90% Accuracy, Wins First Place at GICHD-Sponsored Awards –

Tokyo, Japan, October 29, 2025 — NEC Corporation (NEC; TSE: 6701) and the Cambodian Mine Action Center (CMAC, *1), the national institution responsible for landmine clearance activities in Cambodia, with assistance from JICA (*2), conducted a proof-of-concept using AI to predict landmine-contaminated areas. This initiative aims to contribute to rapid and efficient clearance operations to eliminate landmine casualties. The proof-of-concept achieved highly accurate predictions, with a match rate exceeding 90% against actual landmine locations.

This initiative also received recognition through “The GICHD Innovation Award 2025,” hosted by the Geneva International Centre for Humanitarian Demining (GICHD, *3), which honors outstanding technologies contributing to progress in demining activities. The award was presented at a ceremony held in Luxembourg on Tuesday, October 28.

NEC award recipients (left to right): Dr. Guerkan Solmaz, Dr. Ernoe Kovacs, Dr. Flavio Cirillo

The use of landmines remains a humanitarian issue worldwide, particularly hindering community and economic development for extended periods in post-conflict nations. It is estimated that approximately 100 million people face the threat of landmines, with one person losing their life to a landmine every 90 minutes (*4).

 In Cambodia, civil war spanning the 1970s and 1990s led to the widespread burial of landmines across the country. Despite years of dedicated clearance efforts, remnant landmines persist in some areas today. These landmines prevent the use of land for farming and residential purposes, posing serious obstacles to recovery and development.

The Cambodian government, based on the Ottawa Treaty (Convention on the Prohibition of the Use, Stockpiling, Production and Transfer of Anti-Personnel Mines and on Their Destruction) signed in 1997, has set a target of completing landmine clearance within Cambodia by 2030. To achieve this, it is expected that advanced technologies such as AI will be utilized to reduce survey time.

 This demonstration targeted approximately 1 million square meters of Cambodia’s landmine fields. NEC’s AI analyzed information based on data that included CMAC’s records of detected landmine locations, resident-provided information, and open data such as river/mountainous terrain locations and factory/critical building sites. It then accurately predicted areas with a high probability of containing buried landmines.

 Traditionally, identifying potential landmine-infested areas required extensive, unorganized data and significant manpower over long periods. By leveraging AI, this process can now be performed quickly with fewer personnel, demonstrating the potential to support swift and efficient landmine clearance.

 Going forward, NEC will continue striving to further improve AI’s accuracy. Working with CMAC, with assistance from JICA, and strengthening collaboration with the Japanese government, NEC will accelerate efforts toward achieving Cambodia’s goal of completing landmine clearance by 2030. Furthermore, NEC aims to contribute to other landmine-affected countries using this technology in the future.

(*1) Cambodian Mine Action Center (CMAC). Location: Phnom Penh, Cambodia; Director: Heng Rathana.

(*2) Japan International Cooperation Agency

(*3) Geneva International Center for Humanitarian Demining (GICHD). Location: Geneva, Switzerland; Director: Stefano Toscan

(*4) Source: the-monitor.org/reports/landmine-monitor. Landmine Monitor 2024 Full Paper

About NEC Corporation
NEC Corporation has established itself as a leader in the integration of IT and network technologies while promoting the brand statement of “Orchestrating a brighter world.” NEC enables businesses and communities to adapt to rapid changes taking place in both society and the market as it provides for the social values of safety, security, fairness and efficiency to promote a more sustainable world where everyone has the chance to reach their full potential. For more information, visit NEC at https://www.nec.com or NEC’s Network Solutions at https://www.nec.com/en/global/solutions/5g/index.html.

Our latest News

discover more
AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

AbbVie Announces TEPKINLY® (epcoritamab) in Combination with Lenalidomide and Rituximab is Approved by the European Commission for the Treatment of Relapsed or Refractory Follicular Lymphoma

NORTH CHICAGO, Ill., July 6, 2026 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the European Commission (EC) granted marketing authorization for TEPKINLY® (epcoritamab) in combination with lenalidomide and rituximab (TEPKINLY + R2) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL). The approval is based on results from the pivotal Phase 3 […]

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

Optimized Formula: New Bio-Ink Can Depict the Cell Environment Even More Accurately

It should be biofunctional – that is, it should replicate the natural cellular environment as closely as possible – and it should be printable: bioink. Achieving both of these properties at the same time is an enormous challenge that conventional biomaterials often fail to meet. Together with two partner companies, researchers at the NMI have now taken an important […]

New AI System Provides Treatment Recommendations for Complex Blood Cancers

New AI System Provides Treatment Recommendations for Complex Blood Cancers

Researchers from the German Cancer Research Center (DKFZ), the HI-STEM* Stem Cell Institute, and the Heidelberg University Hospital (UKHD) have developed “HemaGuide,” an AI assistant that supports physicians in making difficult treatment decisions. In extensive testing, the system has shown a high degree of agreement with the recommendations of experienced experts and could significantly improve […]

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp